Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
200 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
2100 Participants Needed
Trial Details
Key Eligibility Criteria
1156 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
1040 Participants Needed
Trial Details
Key Eligibility Criteria
1200 Participants Needed
Trial Details
Key Eligibility Criteria
420 Participants Needed
Trial Details
Key Eligibility Criteria
264 Participants Needed
Trial Details
Key Eligibility Criteria
500 Participants Needed
Trial Details
Key Eligibility Criteria
224 Participants Needed
Trial Details
Key Eligibility Criteria
3680 Participants Needed
Trial Details
Key Eligibility Criteria
992 Participants Needed
Trial Details
Key Eligibility Criteria
421 Participants Needed
Trial Details
Key Eligibility Criteria
3960 Participants Needed
Trial Details
Key Eligibility Criteria
1295 Participants Needed
Trial Details
Key Eligibility Criteria
1875 Participants Needed
Trial Details
Key Eligibility Criteria
406 Participants Needed
Trial Details
Key Eligibility Criteria
838 Participants Needed
Trial Details
Key Eligibility Criteria
510 Participants Needed
Trial Details
Key Eligibility Criteria
1667 Participants Needed
Trial Details
Key Eligibility Criteria
190 Participants Needed
Trial Details
Key Eligibility Criteria
375 Participants Needed
Trial Details
Key Eligibility Criteria
360 Participants Needed
Trial Details
Key Eligibility Criteria
1912 Participants Needed
Trial Details
Key Eligibility Criteria
800 Participants Needed
Trial Details
Key Eligibility Criteria
430 Participants Needed
Trial Details
Key Eligibility Criteria
189 Participants Needed
Trial Details
Key Eligibility Criteria
2050 Participants Needed
Trial Details
Key Eligibility Criteria
1670 Participants Needed
Know someone looking for new options?
Spread the word
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Stamford, CT 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Stamford, CT is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Stamford, CT several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Iadademstat + Atezolizumab/Durvalumab for Small Cell Lung Cancer, Maridebart Cafraglutide for Obesity and Tivozanib + Pembrolizumab for Kidney Cancer to the Power online platform.
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
